BamSEC and AlphaSense Join Forces
Learn More

Veracyte Inc. – Material Contracts

NASDAQ: VCYT    
Share price (6/4/26): $49.94    
Market cap (6/4/26): $3.985 billion

Material Contracts Filter

EX-10.2
from 10-Q 17 pages Veracyte, Inc. Change of Control and Severance Agreement
12/34/56
EX-10.1
from 10-Q 4 pages February 24, 2026 Congratulations! Exceptional Cancer Care Begins With Exceptional People. Welcome to Veracyte! On Behalf of Veracyte, Inc. (NASDAQ: VCYT) (The “Company”), We Are Very Pleased to Offer You the Following Position: Position Title: Chief Development and Technology Officer Reporting To: Marc Stapley, CEO the Terms of This Offer and the Benefits Currently Provided by the Company Are as Follows
12/34/56
EX-10.1
from 8-K 17 pages Veracyte, Inc. 2023 Equity Incentive Plan, as Amended
12/34/56
EX-10.1
from 8-K 17 pages Veracyte, Inc. 2023 Equity Incentive Plan, as Amended
12/34/56
EX-10.29
from 10-K 3 pages Veracyte, Inc. Stock Option Assumption Notice
12/34/56
EX-10.28
from 10-K 14 pages Notice of Option Grant
12/34/56
EX-10.27
from 10-K 27 pages Unless Otherwise Defined, Terms Used Herein Shall Have the Meaning Ascribed to Them in Section 2 Hereof. 1. Purpose; Types of Awards; Construction
12/34/56
EX-10.26
from 10-K 16 pages Veracyte, Inc. Change of Control and Severance Agreement
12/34/56
EX-10.25
from 10-K 5 pages Material contract
12/34/56
EX-10.24
from 10-K 18 pages Veracyte, Inc. Change of Control and Severance Agreement
12/34/56
EX-10.23
from 10-K 1 page August 22, 2023 Current Base Salary Base Salary Increase (%) New Base Salary New Bonus Target Total Target Cash (% Increase) $406,600 $43,400 (11%) $450,000 55% $697,500
12/34/56
EX-10.1
from 10-Q 4 pages Via Email Tina Nova, Phd Re: Advisory Services to Veracyte, Inc
12/34/56
EX-10.2
from 8-K 77 pages Veracyte, Inc. 2023 Equity Incentive Plan Notice of Global Stock Option Grant
12/34/56
EX-10.33
from 10-K 20 pages Veracyte, Inc. Change of Control and Severance Agreement
12/34/56
EX-10.32
from 10-K 1 page Material contract
12/34/56
EX-10.28
from 10-K 11 pages Veracyte, Inc. December 13, 2022
12/34/56
EX-10.6
from 10-Q 8 pages April 20, 2022 Ms. Bonnie Anderson Delivered by Hand or via Email Dear Bonnie
12/34/56
EX-10.5
from 10-Q 12 pages Via Email Re: Terms of Transition and Separation Dear Jane
12/34/56
EX-10.4
from 10-Q 18 pages Veracyte, Inc. Change of Control and Severance Agreement
12/34/56
EX-10.3
from 10-Q 2 pages Ex-10.3 Offer Letter Annie McGuire
12/34/56